[A cytomorphological basis for the correction of radiation-induced immunodeficiencies and hematopoietic depression using thymus and bone marrow peptides].
Comparison in people · 1993
- What was studied
- Clinical participants · 100 across the clinical setting
- Main finding
- A mixed clinical and animal report described immune and hematopoietic recovery with several thymus/bone-marrow preparations, but does not isolate a numerical Thymogen or Thymalin treatment effect.
Reported findings and study design
A mixed clinical and animal report described immune and hematopoietic recovery with several thymus/bone-marrow preparations, but does not isolate a numerical Thymogen or Thymalin treatment effect.
Clinical setting 100 patients; separate experiments in 160 animals; multiple preparations.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Immune and hematopoietic findings | Reported recovery of immune-organ and neutrophil function; reduced asthenia with Thymalin | No preparation-specific comparative numerical outcome supplied |
| Clinical participants | 100 across the clinical setting | Not 100 recipients of each preparation |
| Separate animal experiments | 160 animals | Not human participants |
The patient and animal experiments used different preparations. Their findings apply to the individual preparations tested.
Source for these results ↗ · Reviewed 2026-11-01
Study limitations and source details
Study limitations
- The abstract leaves the preparation and study methods unclear.
- Related publications may share experiments; source count is not independent-study count.
Source details
Indexed metadata and abstract checked via Europe PMC. Original full methods not reviewed.
Sources checked
Citation
Khmel'nitskiĭ OK, Grintsevich II, Kotov VA, Seryĭ SV.. [A cytomorphological basis for the correction of radiation-induced immunodeficiencies and hematopoietic depression using thymus and bone marrow peptides]. Arkhiv patologii
Related compounds
Haemalin
A historical bone-marrow polypeptide extract studied alongside the thymus preparation Thymalin. Haemalin and the later product Bonomarlot have separate formulation records.
Thymohaemin
A historical preparation combining material from thymus and bone marrow. Comparative studies examined it alongside the single-tissue preparations Thymalin and Haemalin.
Thymalin
A mixture of polypeptides extracted from bovine thymus. Human studies examined immune-cell measures and infection outcomes during adjunctive treatment.
Thymogen
A synthetic dipeptide, α-L-glutamyl-L-tryptophan (Glu–Trp, EW). Its alpha peptide bond and L-amino acids distinguish it from the gamma-linked immune peptides Bestim and Thymodepressin.